Biliary atresia is the commonest cause of neonatal liver disease and indication for liver transplantation in children. Biliary atresia, also known as extrahepatic ductopenia and progressive obliterative cholangiopathy, is a childhood disease of the liver in which one or more bile ducts are abnormally narrow, blocked, or absent.

CLINICAL PRESENTATION

  • Mild jaundice and pale stools (the color may fluctuate but becomes increasingly pale as the disease progresses).
  • They have normal birthweight followed by faltering growth.
  • Hepatomegaly is often present initially.
  • Splenomegaly develops due to portal hypertension.

INVESTIGATIONS Blood tests may include:

  • Raised conjugated bilirubin.
  • Abnormal liver function test.
  • Coagulation tests.
  • Viral tests – some viruses can cause liver damage.
  • Tests for some metabolic diseases (such as enzyme deficiencies) that can cause early jaundice and liver test abnormalities.
  • Tests for cystic fibrosis, such as a sweat test.

IMAGING

  • A fasting abdominal ultrasound may demonstrate a contracted or absent gallbladder, though it may be normal.
  • Biliary excretion or “HIDA” scan.
  • The diagnosis is confirmed by a cholangiogram (ERCP (endoscopic retrograde cholangiopancreatography), or operative.
  • Percutaneous liver biopsy is valuable procedure in the evaluation.

Hepatobiliary scintigraphy (HIDA Scan)

Treatment

  • Palliative surgery with a Kasai hepatoportoenterostomy (a loop of jejunum is anastomosed to the cut surface of the porta hepatis) bypasses the fibrotic ducts and facilitates drainage of bile from any remaining patent ductules.
  • Early surgery increases the success rate, with 80% clearing the jaundice if performed before 60 days.
  • Even with successful clearance of jaundice, the disease progresses in most children who may develop cholangitis and cirrhosis with portal hypertension.
  • Nutrition and fat-soluble vitamin supplementation is essential.
  • If the Kasai is unsuccessful, liver transplantation is considered. Biliary atresia is the single most common indication for liver transplantation in the pediatric age group.